These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 29460133)
21. Reduction of ventral prostate weight by finasteride is associated with suppression of insulin-like growth factor I (IGF-I) and IGF-I receptor genes and with an increase in IGF binding protein 3. Huynh H; Seyam RM; Brock GB Cancer Res; 1998 Jan; 58(2):215-8. PubMed ID: 9443394 [TBL] [Abstract][Full Text] [Related]
22. Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men. Yin Z; Yang JR; Rao JM; Song W; Zhou KQ Asian J Androl; 2015; 17(5):826-30. PubMed ID: 25677137 [TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-I produced by seminal vesicles: relationship to intraepithelial basal cell hyperplasia in the prostate. Garcia FU; Urbanska K; Koltowski L; Reiss K; Sell C Clin Cancer Res; 2007 Jun; 13(11):3140-6. PubMed ID: 17545516 [TBL] [Abstract][Full Text] [Related]
24. 5-ARI induces autophagy of prostate epithelial cells through suppressing IGF-1 expression in prostate fibroblasts. Yang BY; Jiang CY; Dai CY; Zhao RZ; Wang XJ; Zhu YP; Qian YX; Yin FL; Fu XY; Jing YF; Han BM; Xia SJ; Ruan Y Cell Prolif; 2019 May; 52(3):e12590. PubMed ID: 30883989 [TBL] [Abstract][Full Text] [Related]
25. The insulin-like growth factor type I receptor stimulates growth and suppresses apoptosis in prostatic stromal cells. Grant ES; Ross MB; Ballard S; Naylor A; Habib FK J Clin Endocrinol Metab; 1998 Sep; 83(9):3252-7. PubMed ID: 9745438 [TBL] [Abstract][Full Text] [Related]
26. Sex hormone-induced prostatic carcinogenesis in the noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer. Wang YZ; Wong YC Prostate; 1998 May; 35(3):165-77. PubMed ID: 9582085 [TBL] [Abstract][Full Text] [Related]
27. [Inhibitory effect of losartan on prostatic hyperplasia in spontaneous hypertension rats and its pathophysiological mechanism]. Shen F; Dong LN; Zhang XY; Zhao XK; Zeng XF; Qu XB Zhonghua Nan Ke Xue; 2012 Jul; 18(7):600-5. PubMed ID: 22994044 [TBL] [Abstract][Full Text] [Related]
28. Are growth factor receptors modulated by metformin in human endometrial stromal cells after stimulation with androgen and insulin? Ferreira GD; Germeyer A; de Barros Machado A; do Nascimento TL; Brum IS; Strowitzki T; von Eye Corleta H; Capp E Arch Gynecol Obstet; 2014 Aug; 290(2):361-7. PubMed ID: 24627035 [TBL] [Abstract][Full Text] [Related]
29. Elevated insulin and reduced insulin like growth factor binding protein-3/prostate specific antigen ratio with increase in prostate size in Benign Prostatic Hyperplasia. Sreenivasulu K; Nandeesha H; Dorairajan LN; Rajappa M; Vinayagam V Clin Chim Acta; 2017 Jun; 469():37-41. PubMed ID: 28300542 [TBL] [Abstract][Full Text] [Related]
30. [Effects of electroacupuncture at "Zhongliao" (BL 33) and "Tianshu" (ST 25) on ovarian function in rats with premature ovarian insufficiency]. Wang W; Wang Y; Wu J; Yang L; Liu Z Zhongguo Zhen Jiu; 2018 May; 38(5):5193-26. PubMed ID: 29797918 [TBL] [Abstract][Full Text] [Related]
31. Insulin-resistance and benign prostatic hyperplasia: the connection. Vikram A; Jena G; Ramarao P Eur J Pharmacol; 2010 Sep; 641(2-3):75-81. PubMed ID: 20553919 [TBL] [Abstract][Full Text] [Related]
32. The influence of orlistat, metformin and diet on serum levels of insulin-like growth factor-1 in obeses women with and without insulin resistance. Kujawska-Luczak M; Szulinska M; Skrypnik D; Musialik K; Swora-Cwynar E; Kregielska-Narozna M; Markuszewski L; Grzymislawska M; Bogdanski P J Physiol Pharmacol; 2018 Oct; 69(5):. PubMed ID: 30683825 [TBL] [Abstract][Full Text] [Related]
33. Icariin ameliorates metabolic syndrome-induced benign prostatic hyperplasia in rats. Aljehani AA; Albadr NA; Nasrullah MZ; Neamatallah T; Eid BG; Abdel-Naim AB Environ Sci Pollut Res Int; 2022 Mar; 29(14):20370-20378. PubMed ID: 34734339 [TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-I (IGF-I) and its binding protein IGFBP-4 in human prostatic hyperplastic tissue: gene expression and its cellular localization. Barni T; Vannelli BG; Sadri R; Pupilli C; Ghiandi P; Rizzo M; Selli C; Serio M; Fiorelli G J Clin Endocrinol Metab; 1994 Mar; 78(3):778-83. PubMed ID: 7510307 [TBL] [Abstract][Full Text] [Related]
36. Protective potential of epigallocatechin-3-gallate against benign prostatic hyperplasia in metabolic syndrome rats. Chen J; Song H Environ Toxicol Pharmacol; 2016 Jul; 45():315-20. PubMed ID: 27348728 [TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats. Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334 [TBL] [Abstract][Full Text] [Related]
38. Insulin-resistance reduces botulinum neurotoxin-type A induced prostatic atrophy and apoptosis in rats. Vikram A; Jena G; Ramarao P Eur J Pharmacol; 2011 Jan; 650(1):356-63. PubMed ID: 20940009 [TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293 [TBL] [Abstract][Full Text] [Related]
40. [Therapeutic effect of Lingze Tablets on benign prostatic hyperplasia in rats: An exploration based on the VEGFA/TNF/IL-6 signaling pathway]. Zhang HN; Sun S; Feng JL; Liu YC; Li HS; Wang JS; Wang B Zhonghua Nan Ke Xue; 2024 Jul; 30(7):634-639. PubMed ID: 39212399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]